69 results
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
to each Purchaser the following:
(i) this Agreement duly executed by the Company;
(ii) a legal opinion and negative assurance letter of Company … on Schedule 3.1(v), the Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance
424B5
8p8bu 2gojtou
1 Feb 24
Prospectus supplement for primary offering
4:49pm
8-K
EX-10.1
m952u4t78ij
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm